Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2533-2539
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2533
Table 3 Treatment modalities for intrahepatic tumor and/or metastatic lung nodule(s)
Treatment modalitiesn (%)
Single treatment modality in treated patients (n = 19)
Hepatectomy4 (21.1)
Pulmonary metastasectomy0 (0)
Transcatheter arterial chemoembolization6 (31.6)
Radiotherapy5 (26.3)
Oral sorafenib4 (21.1)
Combined treatment modalities in treated patients (n = 35)
Hepatectomy + pulmonary metastasectomy3 (8.6)
Hepatectomy + pulmonary metastasectomy + oral sorafenib1 (2.9)
Hepatectomy + transcatheter arterial chemoembolization + radiotherapy6 (17.1)
Hepatectomy + radiotherapy9 (25.7)
Hepatectomy + transcatheter arterial chemoembolization + radiotherapy + oral sorafenib2 (5.7)
Hepatectomy + radiotherapy + oral sorafenib2 (5.7)
Transcatheter arterial chemoembolization + radiotherapy6 (17.1)
Transcatheter arterial chemoembolization + radiotherapy + oral sorafenib3 (8.6)
Transcatheter arterial chemoembolization + oral sorafenib1 (2.9)
Radiotherapy + oral sorafenib2 (5.7)